At a glance
ClinicalIndex Comparison RecordN/ACompleted· 283 enrolled
Drug / intervention
RF Ablation with QDOT Microdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation (PVI) in Subjects With PAF
In Brief
A clinical study evaluating RF Ablation with QDOT Micro for Paroxysmal Atrial Fibrillation. Completed, enrolled 283 participants across 22 sites.
Detailed Summary
Prospective, non-randomized, pre-market clinical evaluation of the QDOT MICRO™ Catheter to demonstrate the safety and effectiveness when compared to an historical control performance goal.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParoxysmal Atrial Fibrillation
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 2018
Enrollment StartJan 2019
Primary CompletionFeb 2022
TodayJul 2026
First PostedDec 14, 2018
Enrollment StartJan 30, 2019
Primary CompletionFeb 17, 2022
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 7.5 years ago
Interventions
RF Ablation with QDOT Microdevice
Subjects will be ablated using QDOT Micro catheter